Investor Presentation First Nine Months of 2023

61 Investor presentation First nine months of 2023 Global obesity market growth has been accelerating with Novo Nordisk capturing the majority of growth 180% 140% 100% 60% Obesity market growth and Novo Nordisk value market share Obesity market size and growth DKK billion 156% 180% 134% 140% 100% 94% 22.8 60% 30.5 ~134% 53.3 0.0 94% ~156% 20% 20% 86% -20% -20% Aug Aug Aug NN Obesity care Others 2020 -NN market share 2023 2022 -Market growth (right axis) Novo Nordisk NN Growth (right axis) Source: IQVIA, Aug 2023 Value MAT, all countries; Share of growth not depicted due to high growth; Market values are based on the list prices Aug 2023 Others Novo NordiskⓇ

View entire presentation